The Patent Finder
MV

Medtronic Vascular, Inc.

Filings on record here from 2001, where this site's data begins
OverviewNotableFeesChangesFamiliesPatent listSources & methods

661 patents currently held

8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.

The next term ends in Jan 2027. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
103
Ending by 2030
Jan 2027
Next term end
469
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
In-Situ Forming Foams for Treatment of Aneurysms US 10,420,862
Cited by 50 later US patents, top 5% of utility patents granted in 2019 in our data. Protection runs to 2032.
Ends Nov 2032 · High confidence
Also notable
Nanoporous Stents with Enhanced Cellular Adhesion and Reduced Neointimal Formation US 9,770,349
Cited by 37 later US patents, top 10% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2031.
Ends Mar 2031 · High confidence
Also notable
Delivery Device for Prosthetic Heart Valve with Capsule Adjustment Device US 10,327,899
Cited by 41 later US patents, top 10% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2035.
Ends Apr 2035 · Medium confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 26, 2026
    The maintenance fee for Blow-Molded Package for a Catheter (US 9,038,822) comes due Nov 26, 2026. Unpaid by May 26, 2027, it lapses early.
  • 9 fees due Dec 16 to 30, 2026 · next Dec 16
  • 5 fees due Jan 4 to 25, 2027 · next Jan 4
  • 10 fees due Feb 4 to 25, 2027 · next Feb 4
  • 12 fees due Mar 1 to 26, 2027 · next Mar 1
  • 19 fees due Apr 1 to 30, 2027 · next Apr 1
  • 13 fees due May 3 to 28, 2027 · next May 3
  • 15 fees due Jun 3 to 30, 2027 · next Jun 3
  • 12 fees due Jul 5 to 28, 2027 · next Jul 5
  • 7 fees due Aug 9 to 23, 2027 · next Aug 9
  • 12 fees due Sep 1 to 30, 2027 · next Sep 1
  • 13 fees due Oct 5 to 30, 2027 · next Oct 5
  • 9 fees due Nov 3 to 17, 2027 · next Nov 3

Which patents, and when each one lapses · Pro

Recent changes

  • 12 of the patents on this record were granted since Aug 23, 2026
  • 17 terms have ended since Aug 23, 2026

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 7,635,382Delivery System for Long Self-Expanding Stents
In force
 · High confidence
In forceHigh confidence
US 7,442,721Durable Biocompatible Controlled Drug Release Polymeric Coatings for Medical Devices
In force
 · High confidence
In forceHigh confidence
US 8,214,015In Vivo Localization and Tracking of Tissue Penetrating Catheters Using Magnetic Resonance Imaging
In force
 · Medium confidence
In forceMedium confidence
US 11,504,223Methods and Apparatus for Treatment of Aneurysms Adjacent Branch Arteries
In force
 · High confidence
In forceHigh confidence
US 7,828,832Intravascular Deployment Device with Improved Deployment Capability
In force
 · High confidence
In forceHigh confidence
US 7,524,331Catheter Delivered Valve Having a Barrier to Provide an Enhanced Seal
In force
 · High confidence
In forceHigh confidence
US 7,481,836Prosthesis with Coupling Zone and Methods
In force
 · High confidence
In forceHigh confidence
US 10,307,244Methods and Apparatus for Treatment of Aneurysms Adjacent Branch Arteries
In force
 · High confidence
In forceHigh confidence
US 7,591,848Riveted Stent Valve for Percutaneous Use
In force
 · High confidence
In forceHigh confidence
US 7,651,527Bioresorbable Stent
In force
 · High confidence
In forceHigh confidence
10 of 661 patents shown.
Pro members see all 661.
Pro members: see all 661 patents
Also on record, not counted in the 661: 8 patents in force now held by others · 329 patents ended · 109 applications pending · 560 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited